19-11007899-TAGG-TAGGAGG
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PM4_Supporting
The NM_001387283.1(SMARCA4):c.2010_2012dupGGA(p.Glu671dup) variant causes a disruptive inframe insertion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001387283.1 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMARCA4 | NM_001387283.1 | c.2010_2012dupGGA | p.Glu671dup | disruptive_inframe_insertion | Exon 14 of 36 | ENST00000646693.2 | NP_001374212.1 | |
| SMARCA4 | NM_003072.5 | c.2010_2012dupGGA | p.Glu671dup | disruptive_inframe_insertion | Exon 14 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.2002-3_2002-2insAGG | splice_acceptor_variant, intron_variant | Intron 13 of 35 | NM_001387283.1 | ENSP00000495368.1 | ||||
| SMARCA4 | ENST00000344626.10 | c.2002-3_2002-2insAGG | splice_acceptor_variant, intron_variant | Intron 13 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
| SMARCA4 | ENST00000643549.1 | c.2002-3_2002-2insAGG | splice_acceptor_variant, intron_variant | Intron 13 of 34 | ENSP00000493975.1 | |||||
| SMARCA4 | ENST00000541122.6 | c.2002-3_2002-2insAGG | splice_acceptor_variant, intron_variant | Intron 14 of 34 | 5 | ENSP00000445036.2 | ||||
| SMARCA4 | ENST00000643296.1 | c.2002-3_2002-2insAGG | splice_acceptor_variant, intron_variant | Intron 13 of 33 | ENSP00000496635.1 | |||||
| SMARCA4 | ENST00000644737.1 | c.2002-3_2002-2insAGG | splice_acceptor_variant, intron_variant | Intron 13 of 33 | ENSP00000495548.1 | |||||
| SMARCA4 | ENST00000589677.5 | c.2002-3_2002-2insAGG | splice_acceptor_variant, intron_variant | Intron 14 of 34 | 5 | ENSP00000464778.1 | ||||
| SMARCA4 | ENST00000643995.1 | c.1414-3_1414-2insAGG | splice_acceptor_variant, intron_variant | Intron 10 of 31 | ENSP00000496004.1 | |||||
| SMARCA4 | ENST00000644963.1 | c.646-3_646-2insAGG | splice_acceptor_variant, intron_variant | Intron 6 of 27 | ENSP00000495599.1 | |||||
| SMARCA4 | ENST00000644065.1 | c.727-3_727-2insAGG | splice_acceptor_variant, intron_variant | Intron 6 of 26 | ENSP00000493615.1 | |||||
| SMARCA4 | ENST00000642350.1 | c.487-3_487-2insAGG | splice_acceptor_variant, intron_variant | Intron 5 of 26 | ENSP00000495355.1 | |||||
| SMARCA4 | ENST00000643857.1 | c.355-3_355-2insAGG | splice_acceptor_variant, intron_variant | Intron 4 of 24 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (Lek 2016); In silico analysis supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 27535533) -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.2010_2012dupGGA variant (also known as p.E672dup), located in coding exon 13 of the SMARCA4 gene, results from an in-frame duplication of GGA at nucleotide positions 2010 to 2012. This results in the duplication of an extra glutamic acid residue between codons 672 and 673. The duplicated amino acid position is well conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at